FDA De Novo For Aletta Creates New Regulatory Category For Robotic Phlebotomy

The FDA clearance of Aletta via De Novo creates a new regulatory pathway for robotic phlebotomy devices in the U.S., establishing a precedent and classification for this emerging category of medical robots.

This Wire brief sits within Fusion42's coverage of Medtech, and 2 sources have reported it.